Clinilabs Drug development Corporation — New York, New York

Clinilabs Drug development Corporation is a clinical research site located in New York, New York, United States 10016.

Crixeo Health Trust Score: 51/100 (POOR). This profile has not yet been claimed by the site owner.

Clinilabs Drug development Corporation has participated in 1 clinical trials.

Therapeutic areas: Major Depressive Disorder.

Sponsors: Ancora Bio, Inc. d/b/a EmbarkNeuro, Inc..

Sponsor Feasibility Report

Trust Score: 51/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Clinilabs Drug development Corporation?

Clinilabs Drug development Corporation has a Crixeo Trust Score of 51/100 (POOR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Clinilabs Drug development Corporation conducted?

Clinilabs Drug development Corporation has 1 clinical trials on record. Their work covers Major Depressive Disorder.

Is Clinilabs Drug development Corporation accredited by Crixeo Health?

Clinilabs Drug development Corporation has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Clinilabs Drug development Corporation?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.